Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer.
Welti, Jonathan
Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer. [electronic resource] - European urology 10 2016 - 599-608 p. digital
Publication Type: Journal Article; Validation Study
1873-7560
10.1016/j.eururo.2016.03.049 doi
Aged
Androstenes--therapeutic use
Antibodies, Monoclonal
Antineoplastic Agents--therapeutic use
Benzamides
Biopsy
Cell Line, Tumor
Cell Nucleus--metabolism
Drug Resistance, Neoplasm
Humans
Immunohistochemistry--methods
Male
Middle Aged
Nitriles
Phenylthiohydantoin--analogs & derivatives
Prognosis
Prostate--pathology
Prostatic Neoplasms, Castration-Resistant--drug therapy
Protein Isoforms--genetics
Receptors, Androgen--genetics
Retrospective Studies
Survival Rate
Time Factors
Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer. [electronic resource] - European urology 10 2016 - 599-608 p. digital
Publication Type: Journal Article; Validation Study
1873-7560
10.1016/j.eururo.2016.03.049 doi
Aged
Androstenes--therapeutic use
Antibodies, Monoclonal
Antineoplastic Agents--therapeutic use
Benzamides
Biopsy
Cell Line, Tumor
Cell Nucleus--metabolism
Drug Resistance, Neoplasm
Humans
Immunohistochemistry--methods
Male
Middle Aged
Nitriles
Phenylthiohydantoin--analogs & derivatives
Prognosis
Prostate--pathology
Prostatic Neoplasms, Castration-Resistant--drug therapy
Protein Isoforms--genetics
Receptors, Androgen--genetics
Retrospective Studies
Survival Rate
Time Factors